Granite Point Capital Management, L.P. Rubius Therapeutics, Inc. Transaction History

Granite Point Capital Management, L.P.

  • $0
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 29, 2019
SELL
$13.5 - $19.94 $497,448 - $734,749
-36,848 Closed
0 $0
Q4 2018

Feb 05, 2019
SELL
$13.83 - $22.97 $1.13 Million - $1.88 Million
-81,852 Reduced 68.96%
36,848 $593,000
Q3 2018

Nov 13, 2018
BUY
$20.06 - $26.94 $2.38 Million - $3.2 Million
118,700 New
118,700 $2.85 Million

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Granite Point Capital Management, L.P. Portfolio

Follow Granite Point Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Granite Point Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email